⌘K

Login Start Free

Home/Filings/4/0000950170-24-043385

4//SEC Filing

Henderson Molly 4

Accession 0000950170-24-043385

CIK 0001783183other

View on SEC.gov Company Profile

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 4:30 PM ET

Size

5.3 KB

Accession

0000950170-24-043385

Insider Transaction Report

Form 4

Period: 2024-04-08

Phathom Pharmaceuticals, Inc.PHAT

Henderson Molly

CFO and CBO

Transactions

Sale
Common Stoock
2024-04-08$11.10/sh−3,435$38,129→ 95,263 total

Holdings

Common Stock
(indirect: By 401(k))
1,911.27

Footnotes (1)

[F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1

filerCIK 0001363812

Filing Metadata

Form type: 4
Filed: Apr 9, 8:00 PM ET
Accepted: Apr 10, 4:30 PM ET
Size: 5.3 KB

View on SEC.gov